Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Microsomal triglyceride transfer protein large subunit | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | hypothetical protein | Get druggable targets OG5_133861 | All targets in OG5_133861 |
Echinococcus granulosus | microsomal triglyceride transfer protein large | Get druggable targets OG5_133861 | All targets in OG5_133861 |
Schistosoma mansoni | hypothetical protein | Get druggable targets OG5_133861 | All targets in OG5_133861 |
Echinococcus multilocularis | microsomal triglyceride transfer protein large | Get druggable targets OG5_133861 | All targets in OG5_133861 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133861 | All targets in OG5_133861 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.1442 | 0.0691 | 0.1122 |
Onchocerca volvulus | Matrilysin homolog | 0.3248 | 0.2304 | 1 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.1442 | 0.0691 | 0.1122 |
Mycobacterium tuberculosis | Probable penicillin-binding protein PbpA | 0.1554 | 0.079 | 0.0218 |
Loa Loa (eye worm) | hypothetical protein | 0.2292 | 0.145 | 0.4817 |
Mycobacterium ulcerans | penicillin-binding protein PbpA | 0.1554 | 0.079 | 0.0107 |
Mycobacterium tuberculosis | Probable bifunctional penicillin-binding protein 1A/1B PonA1 (murein polymerase) (PBP1): penicillin-insensitive transglycosylase | 0.5302 | 0.4139 | 0.754 |
Loa Loa (eye worm) | matrixin family protein | 0.2627 | 0.1749 | 0.627 |
Chlamydia trachomatis | transglycolase/transpeptidase | 0.1554 | 0.079 | 0.5 |
Brugia malayi | Matrixin family protein | 0.3485 | 0.2515 | 1 |
Mycobacterium leprae | POSSIBLE PENICILLIN-BINDING LIPOPROTEIN | 0.1554 | 0.079 | 0.0107 |
Loa Loa (eye worm) | hypothetical protein | 0.1806 | 0.1015 | 0.2701 |
Schistosoma mansoni | hypothetical protein | 0.1679 | 0.0902 | 0.8888 |
Wolbachia endosymbiont of Brugia malayi | cell division protein FtsI | 0.1554 | 0.079 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding lipoprotein | 0.1554 | 0.079 | 0.0218 |
Mycobacterium ulcerans | bifunctional penicillin-binding protein 1A/1B PonA1 | 1.1862 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 1.1862 | 1 | 0.5 |
Mycobacterium ulcerans | penicillin-binding lipoprotein | 0.1554 | 0.079 | 0.0107 |
Brugia malayi | Hemopexin family protein | 0.1679 | 0.0902 | 0.2151 |
Chlamydia trachomatis | transglycolase/transpeptidase | 0.1554 | 0.079 | 0.5 |
Onchocerca volvulus | 0.1679 | 0.0902 | 0.2398 | |
Mycobacterium leprae | PROBABLE BIFUNCTIONAL MEMBRANE-ASSOCIATED PENICILLIN-BINDING PROTEIN 1A/1B PONA2 (MUREIN POLYMERASE) [INCLUDES: PENICILLIN-INSEN | 0.6561 | 0.5264 | 0.4912 |
Mycobacterium ulcerans | penicillin-binding membrane protein PbpB | 0.1554 | 0.079 | 0.0107 |
Loa Loa (eye worm) | matrixin family protein | 0.3485 | 0.2515 | 1 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.1806 | 0.1015 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.2627 | 0.1749 | 0.6989 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.4927 | 0.3804 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2367 | 0.1517 | 0.5143 |
Brugia malayi | 3'5'-cyclic nucleotide phosphodiesterase family protein | 0.2367 | 0.1517 | 0.5143 |
Mycobacterium leprae | Probable penicillin-binding protein PbpA | 0.1554 | 0.079 | 0.0107 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.4927 | 0.3804 | 0.5 |
Treponema pallidum | penicillin-binding protein (pbp-2) | 1.1862 | 1 | 1 |
Mycobacterium tuberculosis | Probable bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 (murein polymerase) [includes: penicillin-insen | 0.6561 | 0.5264 | 1 |
Mycobacterium ulcerans | bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 | 0.6561 | 0.5264 | 0.4912 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.